Northstar Announces Manufacturing And Distribution Deals Signed For First Medical Marijuana Product

NEW YORK: Northstar Global Business Services, Inc., Symbol (OTCPink: MDIN) today announced that it has executed an agreement with Kush Creams, one of the leading Medical marijuana growers and distributors based out of Washington state, to not only manufacture Northstar’s first medical marijuana product, Snorenz Medicated©, but also to distribute the product to marijuana dispensaries throughout the State.

The deal has Kush Creams starting a significant manufacturing run immediately, in order to have enough inventory for the initial orders. It is expected that approximately a hundred dispensaries will start out carrying Snorenz Medicated, and that number is expected to grow significantly as the product begins to capitalize on Snorenz’s existing brand awareness.

Once dispensaries that already carry various Kush Creams products see that Snorenz Medicated is available, it is fully expected that the penetration of the market will increase very quickly. Northstar maintains that its research has shown that many legal marijuana users are already taking some form of Marijuana at night in order to relax and sleep better. Adding THC (the chemical compound contained in marijuana that causes intoxication) to the popular Snorenz formula, not only delivers a good dose of THC, but also lubricates the throat, helping with the “dry mouth” often associated with marijuana, as well as the normal anti-snoring benefits that have made Snorenz Northstar’s biggest seller.